NGEN
NervGen Pharma Corp.
1.90$
+2.7%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | |
| – | +99.3% | +1.2% | +8.1% | +165.7% | +27.1% | -42.3% | -33.4% | |
| – | – | – | – | – | +117.8% | -0.1% | -10.7% | |
| – | -30.0% | +564.5% | -69.3% | +383.3% | -111.5% | – | -21.5% | |
| – | – | – | -19.1% | +654.4% | -73.1% | -100.0% | – | |
| – | – | – | +1,225.2% | -54.0% | +563.8% | – | +71.5% | |
| – | – | – | – | – | +33.3% | +0.0% | +0.0% | |
| – | +182.3% | -22.2% | +151.2% | +13.6% | -96.6% | +2,859.5% | +4.8% | |
| – | -26.8% | -13.1% | +630.7% | -62.7% | -341.0% | – | +4.3% | |
| – | – | – | – | – | – | – | – |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.